FDA Drug Application (021336) for EMSAM by SOMERSET

Back to FDA Applications sponsored by SOMERSET

Application Number021336
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage6MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMSAM
Active IngredientSELEGILINE



Back to FDA Applications sponsored by SOMERSET